|
1
|
Pelcovits A and Niroula R: Acute myeloid leukemia: A review. R I Med J (2013). 103:38–40. 2020.
|
|
2
|
De Kouchkovsky I and Abdul-Hay M: ‘Acute myeloid leukemia: A comprehensive review and 2016 update’. Blood Cancer J. 6:e4412016. View Article : Google Scholar
|
|
3
|
Rose-Inman H and Kuehl D: Acute leukemia. Emerg Med Clin North Am. 32:579–596. 2014. View Article : Google Scholar
|
|
4
|
Narayanan D and Weinberg OK: How I investigate acute myeloid leukemia. Int J Lab Hematol. 42:3–15. 2020. View Article : Google Scholar
|
|
5
|
Infante MS, Piris MÁ and Hernández-Rivas JÁ: Molecular alterations in acute myeloid leukemia and their clinical and therapeutical implications. Med Clin (Barc). 151:362–367. 2018.(In English, Spanish). View Article : Google Scholar
|
|
6
|
Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, et al: Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 129:424–447. 2017. View Article : Google Scholar
|
|
7
|
Medeiros BC: Is there a standard of care for relapsed AML? Best Pract Res Clin Haematol. 31:384–386. 2018. View Article : Google Scholar
|
|
8
|
Daver N, Schlenk RF, Russell NH and Levis MJ: Targeting FLT3 mutations in AML: Review of current knowledge and evidence. Leukemia. 33:299–312. 2019. View Article : Google Scholar
|
|
9
|
Fernandez S, Desplat V, Villacreces A, Guitart AV, Milpied N, Pigneux A, Vigon I, Pasquet JM and Dumas PY: Targeting tyrosine kinases in acute myeloid leukemia: Why, who and how? Int J Mol Sci. 20:34292020. View Article : Google Scholar
|
|
10
|
Li K, Wang F and Hu ZW: Targeting TRIB3 and PML-RARα interaction against APL. Oncotarget. 8:52012–52013. 2017. View Article : Google Scholar
|
|
11
|
Sportoletti P, Celani L, Varasano E, Rossi R, Sorcini D, Rompietti C, Strozzini F, Del Papa B, Guarente V, Spinozzi G, et al: GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations. Leukemia. 33:1827–1832. 2019. View Article : Google Scholar
|
|
12
|
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, et al: FTO plays an oncogenic role in acute myeloid leukemia as a N6-Methyladenosine RNA demethylase. Cancer Cell. 31:127–141. 2017. View Article : Google Scholar
|
|
13
|
Su R, Dong L, Li C, Nachtergaele S, Wunderlich M, Qing Y, Deng X, Wang Y, Weng X, Hu C, et al: R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling. Cell. 172:90–105.e23. 2018. View Article : Google Scholar
|
|
14
|
Damen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, Lassale CM, Siontis GC, Chiocchia V, Roberts C, et al: Prediction models for cardiovascular disease risk in the general population: Systematic review. BMJ. 353:i24162016. View Article : Google Scholar
|
|
15
|
Alaa AM, Bolton T, Di Angelantonio E, Rudd JH and van der Schaar M: Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants. PLoS One. 14:e02136532019. View Article : Google Scholar
|
|
16
|
Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, Natarajan P, Lander ES, Lubitz SA, Ellinor PT and Kathiresan S: Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 50:1219–1224. 2018. View Article : Google Scholar
|
|
17
|
Campbell DD, Li Y and Sham PC: Multifactorial disease risk calculator: Risk prediction for multifactorial disease pedigrees. Genet Epidemiol. 42:130–133. 2018. View Article : Google Scholar
|
|
18
|
Wang Z, Jensen MA and Zenklusen JC: A practical guide to The Cancer Genome Atlas (TCGA). Methods Mol Biol. 1418:111–141. 2016. View Article : Google Scholar
|
|
19
|
eGTEx Project: Enhancing GTEx by bridging the gaps between genotype, gene expression, and disease. Nat Genet. 49:1664–1670. 2017. View Article : Google Scholar
|
|
20
|
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 33:451–458. 1976. View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2011. View Article : Google Scholar
|
|
22
|
Metzeler KH, Hummel M, Bloomfield CD, Spiekermann K, Braess J, Sauerland MC, Heinecke A, Radmacher M, Marcucci G, Whitman SP, et al: Cancer and leukemia group B; German AML cooperative group. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood. 112:4193–4201. 2008. View Article : Google Scholar
|
|
23
|
Wang H, Wu X and Chen Y: Stromal-immune score-based gene signature: A prognosis stratification tool in gastric cancer. Front Oncol. 9:12122019. View Article : Google Scholar
|
|
24
|
Wojcicki AV, Kasowski MM, Sakamoto KM and Lacayo N: Metabolomics in acute myeloid leukemia. Mol Genet Metab. 130:230–238. 2020. View Article : Google Scholar
|
|
25
|
Seth R and Singh A: Leukemias in children. Indian J Pediatr. 82:817–824. 2015. View Article : Google Scholar
|
|
26
|
Skarsgård LS, Andersson MK, Persson M, Larsen AC, Coupland SE, Stenman G and Heegaard S: Clinical and genomic features of adult and paediatric acute leukaemias with ophthalmic manifestations. BMJ Open Ophthalmol. 4:e0003622019. View Article : Google Scholar
|
|
27
|
Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, et al: Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 374:2209–2221. 2016. View Article : Google Scholar
|
|
28
|
Klepin HD, Rao AV and Pardee TS: Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol. 32:2541–2552. 2014. View Article : Google Scholar
|
|
29
|
Yang JJ, Park TS and Wan TS: Recurrent cytogenetic abnormalities in acute myeloid leukemia. Methods Mol Biol. 1541:223–245. 2017. View Article : Google Scholar
|
|
30
|
Kayser S and Levis MJ: Clinical implications of molecular markers in acute myeloid leukemia. Eur J Haematol. 102:20–35. 2019. View Article : Google Scholar
|
|
31
|
Yang X, Wong MP and Ng RK: Aberrant DNA methylation in acute myeloid leukemia and its clinical implications. Int J Mol Sci. 20:45762019. View Article : Google Scholar
|
|
32
|
Li L, Lee KM, Han W, Choi JY, Lee JY, Kang GH, Park SK, Noh DY, Yoo KY and Kang D: Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer. Hum Mol Genet. 19:4273–4277. 2010. View Article : Google Scholar
|
|
33
|
Ghosh SG, Lee S, Fabunan R, Chai G, Zaki MS, Abdel-Salam G, Sultan T, Ben-Omran T, Alvi JR, McEvoy-Venneri J, et al: Biallelic variants in HPDL, encoding 4-hydroxyphenylpyruvate dioxygenase-like protein, lead to an infantile neurodegenerative condition. Genet Med. 23:524–533. 2021. View Article : Google Scholar
|
|
34
|
Ye X, Wei X, Liao J, Chen P, Li X, Chen Y, Yang Y, Zhao Q, Sun H, Pan L, et al: 4-Hydroxyphenylpyruvate dioxygenase-like protein promotes pancreatic cancer cell progression and is associated with glutamine-mediated redox balance. Front Oncol. 10:6171902021. View Article : Google Scholar
|
|
35
|
Reiding KR, Franc V, Huitema MG, Brouwer E, Heeringa P and Heck AJ: Neutrophil myeloperoxidase harbors distinct site-specific peculiarities in its glycosylation. J Biol Chem. 294:20233–20245. 2019. View Article : Google Scholar
|
|
36
|
Yuzhalin AE and Kutikhin AG: Common genetic variants in the myeloperoxidase and paraoxonase genes and the related cancer risk: A review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 30:287–322. 2012. View Article : Google Scholar
|
|
37
|
von Kügelgen I and Wetter A: Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol. 362:310–323. 2000. View Article : Google Scholar
|
|
38
|
Michael IP, Saghafinia S and Hanahan D: A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis. Proc Natl Acad Sci USA. 116:24184–24195. 2019. View Article : Google Scholar
|
